Name: Stem Cells: 2006 Update
Uploaded: undefined
Duration: undefined

NOVA ScienceNOW

The National Science Foundation

NOVA Science Trust Logo

the Alfred P. Sloan Foundation

<div class="rich-text">(This video is no longer available for streaming.) In this story from January 2006, NOVA scienceNOW reports on stunning developments in the field of stem cell research. The South Korean scientist heralded a year earlier for his innovative research is found guilty of fabricating his results, including reportedly groundbreaking work cloning human embryonic stem cells. The Korean fiasco casts a cloud over the field, but U.S. researchers still move forward, believing that embryonic stem cells hold great potential for medicine. As part of this advancement, a team led by Rudolf Jaenisch at MIT explores a way to produce embryonic stem cells without using an embryo that can develop into a fetus.
</div>

A fraudulent South Korean researcher is unmasked, and scientists find a new technique for easing ethical concerns.  

<div class="rich-text">A fraudulent South Korean researcher is unmasked, and scientists find a new technique for easing ethical concerns. </div>

Scientists find a new technique for easing ethical concerns.

Stem Cells: 2006 Update

Body & Brain

<div class="rich-text"><h3>
 STEM CELLS UPDATE
</h3>

 PBS Airdate: January 10, 2006



 ROBERT KRULWICH:
 
 One of the most controversial science stories
of the year involves stem cells, cells that may one day cure terrible diseases.
But the problem with stem cells is they often come from embryos, thus the
phrase "embryonic stem cells." And embryos, while they start no bigger than a
grain of sand, can become babies, so there is a moral issue here.


 But what if—and we're just going to think out loud—what if you
could make an embryonic stem cell without creating an embryo? Could you? Should
you? Well, we know someone who's trying. Reporter Julia Cort has the story.



 JULIA CORT
 
 (Correspondent): As he winds through the
labs of M.I.T., Alex Meissner is trying to sidestep an ethical minefield. He
hopes the tiny cells that float in his Petri dish might hold the key to solving
one of the biggest controversies facing science: whether it's ethical to use
cells from human embryos in medical research.



 RUDOLF JAENISCH:
 
 I believe this research has enormous potential. And it
will revolutionize medicine in the years to come.



 THOMAS BERG:
 
 I don't want to live in a world, I don't think anyone wants
to live in a world, where we're destroying embryos...we're creating them and
destroying them in mass quantities for research purposes.



 JULIA CORT:
 
 While experts debated here, halfway around the
world, South Korea seemed to be forging ahead. Last August, they claimed a
spectacular first, a cloned dog.


 But since then, the Korean king of clones, Hwang Woo-Suk, has been
dethroned, accused of fabricating his results, including groundbreaking work
cloning human embryonic stem cells. The Korean fiasco has cast a cloud over the
field, but U.S. researchers still want to move forward, believing embryonic
stem cells hold great potential for medicine, since they can become any kind of
cell in the human body. But because they come from early human embryos, funding
for the research is extremely limited.



 GEORGE DALEY
 
 (Harvard Stem Cell Institute)
 
 :
 
 Unfortunately, here
in the United States, even though we're chomping at the bit to do the work, the
kind of funding restrictions that we're under, the kind of presidential policy
that we're under, is really the hindrance.



 JULIA CORT:
 
 Physician and researcher George Daley is eager to
create stem cells that are an exact match to sick patients. To do that, he
wants to try cloning technology, but so far, the only cloned cells he's made
belong to mice.



 GEORGE DALEY:
 
 We're essentially frozen in time, at 2001, while the rest
of the world has moved forward very, very aggressively.



 JULIA CORT:
 
 The controversial cloning process would work like
this: take an egg from a woman's ovary, remove its genes or DNA, then, get a
cell—like a skin cell—from a patient, and put its DNA into the egg.
The egg is stimulated to divide, as if it had been fertilized. After a few
days, the early embryo has 50 to 200 cells.


 The goal is to turn some of these into embryonic stem cells that would be a
perfect genetic match to a sick patient. But because the cloned embryo would be
destroyed in the process, critics say this research is wrong. With the
destruction of human embryos at the center of the debate, a few scientists
approached the new year asking if it might be possible to make both sides
happy. What if they could find a way to create embryonic stem cells without
destroying any embryos?



 WILLIAM HURLBUT
 
 (Stanford University)
 
 :
 
 I think it should be
doable.



 JULIA CORT:
 
 Physician and ethicist William Hurlbut thinks the
solution may lie in tinkering with the cloning process.



 WILLIAM HURLBUT:
 
 There's a way to get the cells without creating
embryos. We just have to have the constructive conversation to find the way.



 JULIA CORT:
 
 The challenge intrigued M.I.T.'s Rudolf Jaenisch,
a leading expert on stem cells and cloning. With the help of graduate student
Alex Meissner, Jaenisch tried to create something that would yield stem cells,
but was not an embryo at all.



 RUDOLF JAENISCH:
 
 What is an embryo? What's important? I think an
important part of the sense of an embryo is the potential to develop, to
organize itself.



 JULIA CORT:
 
 The Jaenisch team set out to eliminate that
potential. First, they took a tiny bit of skin from a mouse's tail and let it
grow in culture. With the skin cells growing in a Petri dish, Meissner
concocted a special virus and added it to the skin cells. The virus went to
work and inserted an extra bit of DNA into the skin cell DNA. Meissner
performed the cloning, sucking up a skin cell now containing the extra DNA and
transferring it into a mouse egg. And then the team waited and watched.
Jaenisch's hope was that the extra bit of DNA they'd added 
would
shut down one key gene, a gene that's crucial for organizing the early mouse
embryo and triggering the construction of the placenta.



 RUDOLF JAENISCH:
 
 The placenta, of course, is very important in signaling
the fetus to develop. Without the placenta, it cannot. And the experiment
worked very straightforward. It was actually surprisingly simple to us.



 JULIA CORT:
 
 With that key gene turned off, the unorganized
cluster of cells did not develop normally, and, Jaenisch says, would never
become a baby mouse. But it could be turned into useful stem cells.



 RUDOLF JAENISCH:
 
 The real question is, does it solve the ethical
problem? Some people said yes, others said, "No. It's a particularly devious
way to murder an embryo." I would argue, from the biological point of view, it
is not an embryo. It doesn't qualify to be called this. It doesn't have any
potential whatsoever to ever organize itself to a fetus.



 JULIA CORT:
 
 Father Thomas Berg is encouraged by Jaenisch's
experiment.



 THOMAS BERG:
 
 I think the jury's still out as to whether it's an embryo
or not. But I think it's incredibly interesting, from a moral standpoint, from
a scientific standpoint, obviously. I think what Rudy Jaenisch did holds out
some hope that those of us who do not want to live with a future of
embryo-destructive research, we might have a way out.



 JULIA CORT:
 
 But so far, there is no consensus about the moral
status of what Jaenisch created among stem cell opponents or supporters.



 ARTHUR CAPLAN
 
 (University of Pennsylvania School of Medicine)
 
 :
 
 The scientists who play along, I think, are playing the wrong card. They think,
"Yeah, maybe if I'm clever enough I'll satisfy all the critics." I think the
critics are not going to be satisfied. I think they don't want to see embryonic
stem cell research happen, and I don't think they want to see anything
involving cloning happen.



 JULIA CORT:
 
 Ethical objections have slowed U.S. research. Few
labs have tried to use cloning to make human stem cells, and none have
succeeded. The Korean scandal means that the technique for humans is unproven.
But that, for many U.S. researchers, is all the more reason to keep moving
ahead.



 GEORGE DALEY:
 
 I have patients, and I can see a way to apply this
technology to study their disease and perhaps treat their disease. I want to be
able to use that process today.



 ARTHUR CAPLAN:
 
 If we get diverted into the debate about, "Can we make a
pseudo embryo or an embryo-like thing?," you could spend the next five, 10
years trying to figure out how to tweak an egg or play with embryos. I think,
to spend too much time trying to respond to every possible critic is a recipe
for paralysis, not for breakthroughs.



 ROBERT KRULWICH:
 
 Around the corner, around the world, more
science stories in the news. Hamburg, Germany: toads are exploding at an
alarming rate—1,000 believed dead. And why? Maybe they were bitten and
infected by crows, but, says German scientist Heidi Meyerhofer, "Nein!"



 HEIDI MEYERHOFER
 
 (Translation from German)
 
 :
 
 I have been working
here for 15 years and have never experienced a problem this big with
amphibians. Experts could give no advice about the symptoms.



 ROBERT KRULWICH:
 
 In short, scientists haven't the froggiest
idea.


 Meanwhile, back in the U.S.A. —if you drive, put down the cell phone
because researchers discovered this past year that a normal 30-year-old driver
speaking on a cellular telephone has the reaction time of a 70- or 80-year-old.
Oh dear! Phones and driving prove a deadly mixture. And that's no phony
baloney.
</div>

United States

Northern Mariana Islands

Puerto Rico

American Samoa

Guam

U.S. Virgin Islands

U.S. Minor Outlying Islands

US & Territories

Colossal explosions shake a remote corner of the Siberian tundra, leaving behind massive craters. In Alaska, a huge lake erupts with bubbles of inflammable gas. Scientists are discovering that these mystifying phenomena add up to a ticking time bomb, as long-frozen permafrost melts and releases vast amounts of methane, a potent greenhouse gas. What are the implications of these dramatic developments in the Arctic? Scientists and local communities alike are struggling to grasp the scale of the methane threat and what it means for our climate future. (Premiered February 2, 2022)

In the Arctic, enormous releases of methane, a potent greenhouse gas, threaten the climate.

Arctic Sinkholes

The top half of Jupiter in blue and green against a night sky

A composite image of Jupiter using images captured by the James Webb Space Telescope. Image Credit: NASA, ESA, CSA, Jupiter ERS Team; image processing by Judy Schmidt.

Explore the cosmos, delve into ancient history, and follow an extreme rescue with NOVA’s most-watched documentaries released in 2022.

NOVA’s most popular science documentaries of 2022

Four bright orange loops brand off of a dark blue blob

A transmission electron micrograph of HIV-1 virus particles (orange) replicating from the plasma membrane of an infected H9 T cell. Credit: NIAID, Flickr

Scientists have cured a handful of people of HIV by piggybacking on treatments they received for blood cancer. But does that bring a widespread cure any closer?

Transcript

Credits

Support Provided By